Table 3.

Oligos used in this study for real-time PCR

Oligos	Forward(5ʹ —3ʹ)	Reverse (5ʹ—3ʹ)
FOS	GGGGCAAGGTGGAACAGTTAT	CCGCTTGGAGTGTATCAGTCA
FOSB	GCTGCAAGATCCCCTACGAAG	ACGAAGAAGTGTACGAAGGGTT
EGR1	CCACGCCGAACACTGACATT	GAGGGGTTAGCGAAGGCTG
RIPK1	TGGGCGTCATCATAGAGGAAG	CGCCTTTTCCATGTAAGTAGCA
SPRR3	ATGAGTTCTTACCAGCAGAAGC	GTTCAGGGACCTTGGTGTAGC
APOE	GTTGCTGGTCACATTCCTGG	GCAGGTAATCCCAAAAGCGAC
ZACN	CCTGGGGTTCAGCATTACCTT	GTTGACGTTGAAGAGGGATGG
IGSF3	GCCGAGATTTCATGCTTCACT	CGGAACGCTTTCGGGTCATA
RNA5S1	AACGCGCCCGATCTCGTC	AGGCGGTCTCCCATCCAAGTA
NDUFC2	ACCCAGAACCCTTACGGTTTC	CTCCGCCGGATCAGGTTATC
ADTRP	ACCCCAAGGTCCTAGATACTGT	AAAGCTGCTAGACCCAAGAGG
TGFBI	CTTCGCCCCTAGCAACGAG	TGAGGGTCATGCCGTGTTTC
KRT13	GACCGCCACCATTGAAAACAA	TCCAGGTCAGTCTTAGACAGAG
ENPP2	TCGCTGTGACAACTTGTGTAAG	CCAATGCGACTCTCCTTTGC
GAPDH	CTGGGCTACACTGAGCACC	AAGTGGTCGTTGAGGGCAATG